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Background: Sex-related differences in muscle function have been well established in healthy 
individuals. In individuals with knee osteoarthritis (KOA) impairments in muscle function such as 
muscle weakness and high muscle co-activation have also been demonstrated. Muscle dysfunction 
has been shown to be a strong contributor to poor physical function and low health-related quality 
of life in patients with KOA. The purpose of this study was, therefore, to analyse sex and 
osteoarthritis-related differences in muscle function, to establish to what extent both sex and 
disease status contribute to muscle dysfunction.  
 
Methods: Muscle co-activation was assessed in 77 symptomatic KOA participants (62.5±8.1yrs; 
48/29 women/men) and 18 age-matched asymptomatic controls (62.5±10.4yrs; 9/9 women/men), 
using electromyography (EMG) during a series of walking, stair ascent and descent and sit-to-walk 
activities. EMG was recorded from 7 sites medial/lateral gastrocnemius, biceps femoris, 
semitendinosus, vastus lateralis/medialis and normalised to maximal voluntary contraction. 
Normalised EMG was used to calculate hamstrings-quadriceps and medial-lateral muscle co-
activation as (antagonist/agonist)*(antagonist+agonist). The stance phase of walking was split into 
pre-stance (150ms prior to initial contact), loading (0-15% of stance), early-stance (15-40%), mid-
stance (40-60%), late-stance (60-100%) and overall-stance (0-100%). Stairs negotiation was also split 
into transition (stance phase on the floor) and continuous (stance phase on the second step of the 
staircase). All participants provided written informed consent and the study was approved by 
Research Ethics committees (HLS12/86, 13/ws/0146). Independent samples T-tests were performed 
to assess the differences between KOA and controls. Linear regressions were performed to 
investigate the relationship between muscle function, sex and disease status, and Bonferroni 
corrected for multiple comparisons. 
 
Results: Individuals with KOA were weaker than controls (P<0.007). Overall there were very few 
differences in muscle co-activation between KOA and controls. Women were weaker than men 
(P≤0.002) and had higher hamstrings-quadriceps and medial-lateral muscle co-activation across all 
activities of daily living. In multiple regression analyses sex and muscle weakness, but not age or 
disease status, predicted high muscle co-activation. 
 
Conclusions: High muscle co-activation was associated with female sex and muscle weakness 
regardless of disease status and age. It has previously been suggested that muscle co-activation acts 
as a compensatory mechanism for muscle weakness, accommodating for the diminished force 
generating capabilities to maintain a certain level of function and movement activation patterns. 
This suggests that muscle weakness may be the main contributing factor for high muscle co-
activation which is thought to increase joint loads with detrimental effects on cartilage and joint 
integrity. This may explain high muscle co-activation in women with muscle weakness and increased 
risk of incidence and progression of KOA in women. 
